Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
aTyr Pharma, Inc. - Common Stock
(NQ:
ATYR
)
1.910
-0.090 (-4.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
796,039
Open
1.960
Bid (Size)
1.910 (3)
Ask (Size)
1.950 (10)
Prev. Close
2.000
Today's Range
1.900 - 2.010
52wk Range
1.420 - 2.500
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ATYR Stock Earnings: aTyr Pharma Beats EPS for Q2 2024
August 13, 2024
ATYR stock results show that aTyr Pharma beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update
August 13, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Performance
YTD
+4.95%
+4.95%
1 Month
+13.02%
+13.02%
3 Month
+4.95%
+4.95%
6 Month
+4.95%
+4.95%
1 Year
+4.95%
+4.95%
More News
Read More
aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations
August 06, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Research Study with Stanford Medicine
July 30, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Super League Enterprise And 2 Other Stocks Under $2 Insiders Are Buying
July 25, 2024
Via
Benzinga
aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
July 22, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
ATYR Stock Earnings: aTyr Pharma Beats EPS for Q2 2023
June 10, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.